We are live on
!
Find out more
Atara Biotherapeutics
ATRA
ATRA
134 hedge funds and large institutions have $776M invested in Atara Biotherapeutics in 2022 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 47 increasing their positions, 41 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
471% more call options, than puts
Call options by funds: $2.32M | Put options by funds: $407K
15% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 41
0.07% more ownership
Funds ownership: 4.21% → 4.27% (+0.07%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
7% less funds holding
Funds holding: 144 → 134 (-10)
15% less capital invested
Capital invested by funds: $910M → $776M (-$133M)
27% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 26
Holders
134
Holders Change
-10
Holders Change %
-6.94%
% of All Funds
2.26%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
19
Increased
47
Reduced
41
Closed
26
Calls
$2.32M
Puts
$407K
Net Calls
+$1.92M
Net Calls Change
+$475K
Top Buyers
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$8.51M |
| 2 |
BlackRock
New York
|
+$6.3M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
+$4.86M |
| 4 |
JP Morgan Chase
New York
|
+$4.38M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$4.03M |
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$4.57M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
-$3.55M |
| 3 |
Millennium Management
New York
|
-$2.49M |
| 4 |
Renaissance Technologies
New York
|
-$2.25M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.8M |
